Browse by Medical Category
Talk to an access nurse today
The Claire & John Bertucci Center for Genitourinary Cancers is one of the largest and most experienced centers in New England for the diagnosis and treatment of testicular cancer.
Our Specialists use advanced approaches to diagnose and treat testicular cancer. Many of these approaches were developed at the Mass General Cancer Center, and may include:
New patients are generally seen within a week of referral. In keeping with your needs and wishes, we will develop your individually tailored treatment plan, monitor your care, and communicate regularly with you and your referring physician about your progress.
Exact diagnosis and staging are critical to finding the righttreatment for your cancer. Our team includes highly sub-specialized pathologists who work exclusively with genitourinary cancers. They look for tumor markers that can help pinpoint prognosis (outlook) and treatment approach. This translates into quick, accurate staging of genitourinary cancers – the foundation of an appropriate treatment plan.
Our diagnostic experts are aided by advanced methods for diagnosing and staging testicular cancer, particularly new MRI techniques, including diffusion-weighted MRI, which more accurately detect cancer cells. In clinical trials, nanoparticle-enhanced MRI (developed at the Mass General Cancer Center) has shown promise for detecting cancerous lymph nodes that traditional biopsy methods may miss.
We perform a large number of testicular cancer diagnostic and treatment procedures annually. Studies have shown patients do better when they are treated in a facility that cares for a high number of patients with the same form of cancer. Other notable aspects of having genitourinary cancer surgery here include:
Our radiation oncologists use the most advanced imaging techniques and delivery technology. Care is taken to not only target the affected tissues with precision but also to deliver the lowest possible radiation dose to the healthy normal tissues.
Learn more about radiation therapy.
New patients are generally seen within a week of referral. At your first appointment, you will meet the genitourinary cancer specialists who will be involved in your care, including:
In addition, you may also see:
Matthew R. Smith, MD, PhDDirector, Genitourinary Malignancies Program
Testicles are part of the male reproductive system. They produce sperm and several male hormones, including testosterone. Cancer that begins in the tissues of a testicle is called testicular cancer.
The American Cancer Society (ACS) estimates that about 8,430 new cases of testicular cancer would be diagnosed in the United States in 2015, and that the disease would cause about 380 deaths. It is one of the most curable forms of cancer.
After a medical history and physical examination are completed, testicular cancer may be diagnosed by an orchiectomy, the surgical removal of one or both testicles and surrounding structures. The testicle(s) is then studied to determine if it is cancerous.>
In addition to an orchiectomy, treatment for testicular cancer may involve one or more of these options:
Clinical trials are research studies of new drugs, new combinations of drugs or already approved drugs being studied to treat patients in new and different ways. They may include new drug doses or new ways (schedules) to give the drugs. Clinical trials are run under strict guidelines. Their purpose is to help find out whether new cancer treatments are safe and effective or better than the standard (current) treatment. At Massachusetts General Hospital Cancer Center, there are several clinical trials open for the treatment of breast cancer that use the latest in cancer treatments.
Cancer is increasingly becoming a disease in which the genetic make-up of each individual cancer drives therapy. The Center for Genitourinary Cancers also has access to clinical trials involving these targeted therapy approaches.
The Cancer Center also offers the Lazarex-MGH Cancer Care Equity Program, which strives to promote awareness about and access to cancer clinical trials through community outreach and education, financial assistance, and patient navigation. Learn more about this program.
If you have any questions or would like to speak with one of our doctors, please call the Claire and John Bertucci Center for Genitourinary Cancers at 617-724-4000.
Back to Top